Traws Pharma, Inc.TRAWNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank50
3Y CAGR+11.5%
5Y CAGR+1.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+11.5%/yr
vs -5.1%/yr prior
5Y CAGR
+1.7%/yr
Recent acceleration
Acceleration
+16.6pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $27.50M | -44.5% |
| 2024 | $49.56M | +141.5% |
| 2023 | $20.52M | +3.4% |
| 2022 | $19.85M | +18.7% |
| 2021 | $16.72M | -33.7% |
| 2020 | $25.22M | +5.6% |
| 2019 | $23.88M | -2.3% |
| 2018 | $24.45M | -7.5% |
| 2017 | $26.44M | -9.3% |
| 2016 | $29.15M | - |